Join
Live feed
·
PRReleasevia Quantisnow
Nkarta Inc. logo

Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers

ByQuantisnow·Wall Street's wire, on your screen.
NKTX· Nkarta Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NKTX (Nkarta Inc.) and more on Quantisnow.